Reuters: U.S.

Tuesday, April 21, 2020

Overnight Healthcare: Senate passes $484B coronavirus relief package | Georgia faces pressure to reconsider its reopening | CDC director warns second wave of coronavirus might be 'more difficult'

 
 
View in Browser
 
The Hill Healthcare
Facebook   Twitter   LinkedIn   Email
 

 

Welcome to Tuesday’s Overnight Health Care. 

There are more than 800,000 confirmed COVID-19 cases in the U.S., and the death toll is rapidly approaching 45,000.

Meanwhile, the Senate passed a $484 billion interim coronavirus relief package, and Georgia Gov. Brian Kemp (R) is facing backlash after announcing some businesses including bowling alleys and hair salons would be allowed to open Friday. 

Let’s start with the Senate: 

Senate passes $484B coronavirus relief package

There’s a deal! And it passed the Senate. 

The price tag for the “interim” legislation is still a hefty $484 billion. How that breaks down:

  • $310 billion for small business relief, including $60 billion specifically for community banks and smaller lenders.
  • $75 billion for hospitals
  • $25 billion for testing 
  • $60 billion for emergency disaster loans and grants

Highlighting the need: Forty-three percent of respondents to a Pew Research Center survey released Tuesday said they had either had their wages cut or lost their job due to the coronavirus pandemic.

The backstory: Senate Majority Leader Mitch McConnell (R-Ky.) and Senate Democrats initially tried to pass their own dueling proposals nearly two weeks ago, but both were blocked. McConnell was offering a clean additional $250 billion for the small business aid program, while Democrats wanted to add in an additional $100 billion for hospitals, $150 billion for state and local governments and a boost in food stamp assistance. 

McConnell took a victory lap on Tuesday, arguing that Democrats had dropped “a number of their unrelated demands” during the negotiations.

Democrats noted they successfully added money for hospitals, testing, and other priorities. 

Read more here.

Georgia faces pressure to reconsider its reopening

Georgia is coming under pressure to reconsider its plans to begin allowing some businesses to open at the end of the week, even as the state has seen an uptick in coronavirus cases.

GOP senators, former Trump administration officials, health experts, Georgia mayors and Democrats are expressing outrage and concern, saying Gov. Brian Kemp, a Republican, is risking an explosion of new coronavirus cases that could lead to a second economic shutdown for the state.

Intra-GOP criticism: Sen. Lindsay Graham (R), who hails from bordering South Carolina, said Tuesday that he’s worried Georgia is “moving too fast too soon.”

“We respect Georgia’s right to determine its own fate,” Graham tweeted. “But we are all in this together. What happens in Georgia will impact us in South Carolina.”

Read more here.

Related: Wisconsin legislature sues to block enforcement of governor's stay-at-home order

Missouri becomes first state to sue China over coronavirus response

Massachusetts extends school closures through end of school year

Illinois governor: Trump encouraging coronavirus protests is 'fomenting some violence' 

Illinois Gov. J.B. Pritzker (D) is not a fan of President Trump’s apparent endorsement of public protests against social distancing measures, saying Tuesday that the president is “fomenting some violence.”

“I’m very disappointed with the rhetoric and messaging coming from the president,” Pritzker said in a livestream with The Washington Post, saying that officials in Illinois have been collaborating across party lines during the coronavirus pandemic.

"He’s fomenting protests and I hate to say, that is fomenting some violence, and I’m very concerned about what it might mean for the country if he keeps doing things like that.”

President Trump has said states will make their own decisions about when they're ready to open up their economies, but he and members of his administration have questioned and criticized some states — blue states, mostly — that are not ready to move as quickly.

Read more here

Related: Barr: Some governors' action 'infringes on a fundamental right' during coronavirus

Director of agency behind vaccine development leaves role 

This move set off some questions: The director of the federal agency that invests in vaccines, drugs and diagnostics to combat infectious diseases has departed.

Rick Bright is no longer director of the Biomedical Advanced Research and Development Authority, according to a Department of Health and Human Services spokesperson. 

Instead, Bright will work on diagnostic testing development at the National Institutes of Health.  

Bright's departure was first reported by Stat News.

BARDA is a small agency within HHS that was created in 2006 to help invest in drug and vaccine development projects for pandemic diseases like Ebola or Zika.

Read more here

NYC to create its own stockpile of medical supplies: 'It's sobering as all hell'

New York City will create its own stockpile of medical supplies after Mayor Bill de Blasio (D) said Tuesday that the city “can’t depend on the federal government.”

De Blasio announced the development of the local stockpile at his Tuesday press conference, saying it will include surgical gowns, test kits and ventilators. The city will still purchase necessary medical supplies from outside vendors. 

States and cities have been competing with each other and the federal government to purchase needed medical supplies, and in some instances the federal government has gone so far as to seize supplies intended for somewhere else. 

Read more here

Largest analysis of hydroxychloroquine use finds no benefit for coronavirus, increased deaths

An anti-malaria drug touted by President Trump as a potential "game changer" amid the coronavirus outbreak showed no benefit for patients, according to an analysis of those hospitalized in Veterans Health Administration medical centers.

The analysis found the two primary outcomes for COVID-19 patients treated with hydroxychloroquine were death and the need for mechanical ventilation. 

The analysis was conducted retrospectively, based on data from patients hospitalized with confirmed coronavirus infections in all Veterans Health Administration medical centers until April 11.

The study analyzed only 368 patients but represented the largest look at the outcomes of COVID-19 patients treated with hydroxychloroquine — with or without azithromycin, a common antibiotic — anywhere in the world.

Caveat: The study is a preprint, meaning it was submitted for publication to the New England Journal of Medicine but has not been peer-reviewed. 

Read more here

Related: NIH recommends against combining hydroxychloroquine with Z-Pak to treat COVID-19

CDC director warns second wave of coronavirus might be 'more difficult'

A potential second wave of the novel coronavirus late in the year would likely be more deadly, as it would overlap with flu season, Centers for Disease Control and Prevention (CDC) head Robert Redfield told The Washington Post on Tuesday.

“There’s a possibility that the assault of the virus on our nation next winter will actually be even more difficult than the one we just went through,” Redfield told the Post. “And when I’ve said this to others, they kind of put their head back, they don’t understand what I mean.”

Redfield said two coinciding respiratory outbreaks would strain the nation’s health care system even further than the current pandemic, which has been marked by shortages of ventilators, test kits and personal protective equipment.

Americans can make such a scenario less likely, he said, by keeping up to date on flu vaccinations, which he said “may allow there to be a hospital bed available for your mother or grandmother that may get coronavirus.”

Read more here

What we’re reading

What happens if U.S. reopens too fast? Documents show federal coronavirus projections (Center for Public Integrity)

The quiet hand of conservative groups in the anti-lockdown protests (New York Times)

Amazon workers stage new protests over warehouse coronavirus safety (NPR)

State by state

Has the peak passed in Mass.? What we’ve learned from new coronavirus data (NBC)   

S.C. beaches reopen — or not — reflecting a divide over coronavirus shutdown (NPR)

Louisiana Coronavirus Updates: Cases remain steady as leaders begin easing restrictions (WWL)

Gretchen Whitmer: I have made gut-wrenching choices to keep people safe (New York Times oped

Op-eds in The Hill

Healthy food: The unexpected medicine for COVID-19 and national security

We need to rethink employer-provided health insurance

 

 

 
 
 
 
  Facebook   Twitter   LinkedIn   Email  
 
Did a friend forward you this email?
Sign up for Healthcare Newsletters  
 
 
 
 
 
THE HILL
 
Privacy Policy  |  Manage Subscriptions  |  Unsubscribe  |  Email to a friend  |  Sign Up for Other Newsletters
 
The Hill 1625 K Street, NW 9th Floor, Washington DC 20006
©2020 Capitol Hill Publishing Corp., a subsidiary of News Communications, Inc.
 
 
Link

No comments:

Post a Comment